Impulse control disorders
Important: Impulse control disorders (ICDs) can develop in a person with Parkinson’s disease on any dopaminergic therapy, at any stage of the disease.
🧠 About
- ICDs are a recognised complication of Parkinson’s treatment, most strongly linked with dopamine agonists but can occur with levodopa too.
- They represent maladaptive reward-seeking behaviours triggered by overstimulation of mesolimbic dopaminergic pathways.
🔎 Clinical Presentation
- Pathological Gambling 🎰
- Hypersexuality ❤️🔥
- Compulsive Shopping 🛍️
- Binge Eating 🍫
- Punding 🔧 - stereotyped, repetitive handling of objects (e.g., disassembling gadgets, sorting items, skin-picking).
💊 Common Causative Medications
- Levodopa/Benserazide (Madopar)
- Typical daily dose: 300–800 mg levodopa (divided).
- Started at 50–100 mg tds, titrated gradually.
- Levodopa/Carbidopa (Sinemet)
- Typical daily dose: 300–1,000 mg levodopa (divided).
- Common start: 100/25 mg tds.
- Dopamine Agonists
- Pramipexole: start 0.125–0.25 mg tds, titrate up to ~1.5 mg tds.
- Ropinirole: start 0.25 mg tds, titrate up to ~8 mg tds.
- Rotigotine patch: start 2 mg/24h, titrate to 8 mg/24h (or more).
🛠️ Management of ICDs
- Medication Adjustment
- Reduce or stop the dopamine agonist first (most strongly associated).
- Rebalance Parkinson’s drug regimen (consider levodopa dominance, COMT inhibitors, MAO-B inhibitors).
- Non-Pharmacological Support
- Cognitive–behavioural therapy for compulsive behaviours.
- Family education & close monitoring for relapse.
- Lifestyle and psychosocial interventions to reduce triggers.
Pearl for exams 📝: If a Parkinson’s patient develops sudden gambling, hypersexuality, or compulsive spending, always suspect dopamine agonists and adjust medication.